These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1289 related articles for article (PubMed ID: 33712848)

  • 1. DDIWAS: High-throughput electronic health record-based screening of drug-drug interactions.
    Wu P; Nelson SD; Zhao J; Stone CA; Feng Q; Chen Q; Larson EA; Li B; Cox NJ; Stein CM; Phillips EJ; Roden DM; Denny JC; Wei WQ
    J Am Med Inform Assoc; 2021 Jul; 28(7):1421-1430. PubMed ID: 33712848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mining clinical text for signals of adverse drug-drug interactions.
    Iyer SV; Harpaz R; LePendu P; Bauer-Mehren A; Shah NH
    J Am Med Inform Assoc; 2014; 21(2):353-62. PubMed ID: 24158091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mining and visualizing high-order directional drug interaction effects using the FAERS database.
    Yao X; Tsang T; Sun Q; Quinney S; Zhang P; Ning X; Li L; Shen L
    BMC Med Inform Decis Mak; 2020 Mar; 20(Suppl 2):50. PubMed ID: 32183790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
    Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
    BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Shared Electronic Health Record Systems on Drug-Drug Interaction and Duplication Warning Detection.
    Rinner C; Grossmann W; Sauter SK; Wolzt M; Gall W
    Biomed Res Int; 2015; 2015():380497. PubMed ID: 26682218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval.
    Lorberbaum T; Sampson KJ; Woosley RL; Kass RS; Tatonetti NP
    Drug Saf; 2016 May; 39(5):433-41. PubMed ID: 26860921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in high-priority drug-drug interaction alerts across institutions and electronic health records.
    McEvoy DS; Sittig DF; Hickman TT; Aaron S; Ai A; Amato M; Bauer DW; Fraser GM; Harper J; Kennemer A; Krall MA; Lehmann CU; Malhotra S; Murphy DR; O'Kelley B; Samal L; Schreiber R; Singh H; Thomas EJ; Vartian CV; Westmorland J; McCoy AB; Wright A
    J Am Med Inform Assoc; 2017 Mar; 24(2):331-338. PubMed ID: 27570216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis.
    Dechanont S; Maphanta S; Butthum B; Kongkaew C
    Pharmacoepidemiol Drug Saf; 2014 May; 23(5):489-97. PubMed ID: 24616171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reactions caused by drug-drug interactions in cardiovascular disease patients: introduction of a simple prediction tool using electronic screening database items.
    Kovačević M; Vezmar Kovačević S; Radovanović S; Stevanović P; Miljković B
    Curr Med Res Opin; 2019 Nov; 35(11):1873-1883. PubMed ID: 31328967
    [No Abstract]   [Full Text] [Related]  

  • 10. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.
    Leone R; Magro L; Moretti U; Cutroneo P; Moschini M; Motola D; Tuccori M; Conforti A
    Drug Saf; 2010 Aug; 33(8):667-75. PubMed ID: 20635825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic drug-drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management.
    Zhou YT; Yu LS; Zeng S; Huang YW; Xu HM; Zhou Q
    Ther Clin Risk Manag; 2014; 10():17-26. PubMed ID: 24379677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of drug-drug interactions through data mining studies using clinical sources, scientific literature and social media.
    Vilar S; Friedman C; Hripcsak G
    Brief Bioinform; 2018 Sep; 19(5):863-877. PubMed ID: 28334070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracting drug-enzyme relation from literature as evidence for drug drug interaction.
    Zhang Y; Wu HY; Du J; Xu J; Wang J; Tao C; Li L; Xu H
    J Biomed Semantics; 2016; 7():11. PubMed ID: 26955465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial Intelligence and Data Mining for the Pharmacovigilance of Drug-Drug Interactions.
    Hauben M
    Clin Ther; 2023 Feb; 45(2):117-133. PubMed ID: 36732152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data.
    Somogyi-Végh A; Ludányi Z; Erdős Á; Botz L
    BMC Pharmacol Toxicol; 2019 May; 20(1):36. PubMed ID: 31151485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
    Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
    J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-drug interaction discovery and demystification using Semantic Web technologies.
    Noor A; Assiri A; Ayvaz S; Clark C; Dumontier M
    J Am Med Inform Assoc; 2017 May; 24(3):556-564. PubMed ID: 28031284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancement in predicting interactions between drugs used to treat psoriasis and its comorbidities by integrating molecular and clinical resources.
    Patrick MT; Bardhi R; Raja K; He K; Tsoi LC
    J Am Med Inform Assoc; 2021 Jun; 28(6):1159-1167. PubMed ID: 33544847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial computerized provider order-entry system: Override appropriateness and adverse drug events.
    Edrees H; Amato MG; Wong A; Seger DL; Bates DW
    J Am Med Inform Assoc; 2020 Jun; 27(6):893-900. PubMed ID: 32337561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-drug interactions in inpatient and outpatient settings in Iran: a systematic review of the literature.
    Nabovati E; Vakili-Arki H; Taherzadeh Z; Hasibian MR; Abu-Hanna A; Eslami S
    Daru; 2014 Jun; 22(1):52. PubMed ID: 24965959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.